Description
PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA 10/20
15 G Aerosol
DOSIS: 75/5 MG
Uso exclusivo en entornos hospitalarios
KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
HILO DENT GUM EXPANDING 40 MTS ALCANFOR 5.26 G MENTOL 2.82 G PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA1 Pieza Caja
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Protectores de Palma Toallas
US$ 12.00
Morral Nike Air 21L Relojes Mujer
US$ 26.80
Morral Brasilia 18L Franklin
US$ 52.00





